Last reviewed · How we verify
Menopausal flushing
Approved treatments
- Xyosted (Autoinjector) · Endo
- Delestrogen · Ph Health
Delestrogen works by binding to estrogen receptors in the body, mimicking the effects of natural estrogen. - Micronor · Johnson & Johnson
ORIAHNN combines elagolix, which suppresses LH and FSH to reduce ovarian sex hormones, with estradiol and norethindrone acetate to mitigate side effects. - Estrace · Pfizer
Estrace works by binding to estrogen receptors in the body, mimicking the effects of natural estrogen. - Depo-Provera · Pfizer
Depo-Provera works by binding to the progesterone receptor in the body, which helps to regulate the menstrual cycle and prevent pregnancy. - Androgel · Besins Hlthcare
- Testosterone Cypionate · Azurity
- Premarin · Pfizer
- Jadelle · Fdn Consumer
Jadelle works by binding to the progesterone receptor, which helps to prevent ovulation and thicken cervical mucus to prevent sperm from reaching the egg. - Endometrin · Ferring
- Testosteron · Gulhane School of Medicine
- Ortho-Novum 10/11-21 · Merck & Co.
- Estring · Pfizer Inc.
Prevents pregnancy primarily by suppressing ovulation. - Testosterone cypionate (200mg/3ml) · Leticia Maria Defendi Barboza Marson
- Depoestradiol · Pfizer
- Duavee · Wyeth Pharms Pfizer
DUAVEE combines conjugated estrogens and bazedoxifene to activate estrogen receptors while reducing endometrial hyperplasia risk. - Slynd · Exeltis Usa Inc
Slynd works by binding to the mineralocorticoid receptor, a protein that plays a role in hormone regulation. - Testred · Bausch Health
- Premarin · Pfizer
Conjugated estrogens bind to nuclear estrogen receptors in estrogen-responsive tissues, modulating gonadotropin secretion and reducing elevated LH and FSH in postmenopausal women. - Progesteron · Minia University
Clinical guidelines
- FDA label — 1L
PREMARIN is indicated for the treatment of moderate to severe vasomotor symptoms due to menopause. - FDA label — 1L
PREMARIN is indicated for the treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause. Topical vaginal products should be considered when prescribing solely for this indication.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Menopausal flushing patent landscape — cliff calendar, originator estates, attackable patents
- Menopausal flushing treatment landscape brief
- Menopausal flushing treatment updates RSS
Frequently asked questions about Menopausal flushing
What drugs treat Menopausal flushing?
Tracked treatments include Xyosted (Autoinjector), Delestrogen, Micronor, Estrace, Depo-Provera, Androgel, Testosterone Cypionate, Premarin.
What is the treatment for Menopausal flushing?
Standard treatment for Menopausal flushing includes Xyosted (Autoinjector), Delestrogen, Micronor, Estrace, Depo-Provera. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Menopausal flushing?
FDA label publishes guidelines for Menopausal flushing. 2 guideline references tracked.
Related
- Treatment landscape: Menopausal flushing patent cliff · Menopausal flushing CI report
- Treatment: Xyosted (Autoinjector) · Endo
- Treatment: Delestrogen · Ph Health
- Treatment: Micronor · Johnson & Johnson
- Treatment: Estrace · Pfizer
- Treatment: Depo-Provera · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing